Balyasny Asset Management LLC Annexon, Inc. Transaction History
Balyasny Asset Management LLC
- $57.8 Billion
- Q1 2025
A detailed history of Balyasny Asset Management LLC transactions in Annexon, Inc. stock. As of the latest transaction made, Balyasny Asset Management LLC holds 96,752 shares of ANNX stock, worth $236,074. This represents 0.0% of its overall portfolio holdings.
Number of Shares
96,752Holding current value
$236,074% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding ANNX
# of Institutions
145Shares Held
96.6MCall Options Held
36.9KPut Options Held
83K-
Satter Management Co., L.P.7.41MShares$18.1 Million71.99% of portfolio
-
Bvf Inc San Francisco, CA7MShares$17.1 Million0.59% of portfolio
-
Black Rock Inc. New York, NY6.59MShares$16.1 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA6.3MShares$15.4 Million1.28% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.37MShares$13.1 Million0.0% of portfolio
About Annexon, Inc.
- Ticker ANNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,617,700
- Market Cap $116M
- Description
- Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...